Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 12Non-Muscle Invasive Bladder Neoplasms 4Carcinoma, Transitional Cell 2Ureteral Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Muscle Invasive Bladder Urothelial Carcinoma 1Kidney Neoplasms 1Hematuria 1Carcinoma in Situ 1

Interventions

enzalutamide 92Magnetic Resonance Spectroscopy 87Specimen Handling 66Prednisone 65Androgen Antagonists 59Abiraterone Acetate 59apalutamide 56Radiosurgery 53Radiotherapy 47Leuprolide 47darolutamide 46abiraterone 44Docetaxel 43Radiation 31Pluvicto 31acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 30Biopsy 30relugolix 28Surveys and Questionnaires 28pembrolizumab 26gallium 68 PSMA-11 26Standard of Care 26Triptorelin Pamoate 25Goserelin 25bicalutamide 23Gonadotropin-Releasing Hormone 23Brachytherapy 21Carboplatin 20X-Rays 19luprolide acetate gel depot 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Cystoscopy × 1 year × Clear all
NCT05438563 2025-09-09

MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer

Mayo Clinic

Phase NA Recruiting
100 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡